This is a Validated Antibody Database (VAD) review about human UBE2C, based on 2 published articles (read how Labome selects the articles), using UBE2C antibody in all methods. It is aimed to help Labome visitors find the most suited UBE2C antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
UBE2C synonym: UBCH10; dJ447F3.2; ubiquitin-conjugating enzyme E2 C; (E3-independent) E2 ubiquitin-conjugating enzyme C; E2 ubiquitin-conjugating enzyme C; cyclin-selective ubiquitin carrier protein; mitotic-specific ubiquitin-conjugating enzyme; ubiquitin conjugating enzyme E2C; ubiquitin-protein ligase C

Abcam
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:300; loading ...; fig 1b
  • western blot; human; 1:1000; loading ...; fig 1c
Abcam UBE2C antibody (Abcam, ab12290) was used in immunohistochemistry - paraffin section on human samples at 1:300 (fig 1b) and in western blot on human samples at 1:1000 (fig 1c). Oncotarget (2016) ncbi
Sigma-Aldrich
mouse monoclonal (9D3)
  • western blot; human; loading ...; fig 1b
In order to investigate the involvement of RNF8- and Ube2S-dependent ubiquitin lysine 11-linkage modification in the DNA damage response, Sigma-Aldrich UBE2C antibody (Sigma Aldrich, WH0011065M1) was used in western blot on human samples (fig 1b). Mol Cell (2017) ncbi
Articles Reviewed
  1. Paul A, Wang B. RNF8- and Ube2S-Dependent Ubiquitin Lysine 11-Linkage Modification in Response to DNA Damage. Mol Cell. 2017;66:458-472.e5 pubmed publisher
  2. Wang W, Wang Z, Zhao J, Wei M, Zhu X, He Q, et al. A novel molecular and clinical staging model to predict survival for patients with esophageal squamous cell carcinoma. Oncotarget. 2016;7:63526-63536 pubmed publisher